Skip to main content

Table 2 Change between baseline and week 24 for secondary outcomes

From: Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial

  Omega three Control Mean difference
(Omega three minus Control)
p
Weight (kg) 0.23 (0.49)  − 0.05 (0.46) 0.28 (− 1.09 to 1.65) 0.68
BMI (kg/m2)  − 0.01 (0.16) 0.03 (0.15)  − 0.04 (− 0.419 to 0.41) 0.86
eGFR (ml/min/1.73m2)  − 2.7 (1.5)  − 1.5 (1.4)  − 1.2 (− 5.3 to 2.9) 0.56
Cholesterol (mmol/l) 0.23 (0.13)  − 0.11 (0.12) 0.34 (− 0.03 to 0.71) 0.07
Triglycerides (mmol/l)  − 0.38 (0.18)  − 0.16 (0.16)  − 0.22 (− 0.71 to 0.27) 0.37
HDL (mmol/l) 0.07 (0.04) 0.02 (0.04) 0.05 (− 0.07 to 0.18) 0.39
LDL (mmol/l) 0.31 (0.11)  − 0.06 (0.10) 0.37 (0.07 to − 0.66) 0.02
Cholesterol (total/LDL) 0.06 (0.19)  − 0.09 (0.18) 0.15 (− 0.37 to 0.67) 0.57
HbA1c (mmol/mol) 1.08 (1.0) 0.77 (0.92) 1.85 (− 0.94 to 4.64) 0.19
Oxypurinol(µmol/l)  − 2.2 (10.9) 12.7 (9.7)  − 14.9 (− 47.3 to 17.4) 0.34
Total omega 3 (%) 5.69 (0.57) 0.38 (0.53) 5.31 (3.72 to 6.90)  < 0.001
20:5n-3 (EPA)% 2.90 (0.34)  − 0.04 (0.32) 2.93 (1.99 to 3.88)  < 0.001
22:6n-3 (DHA)% 2.15 (0.23) 0.14 (0.22) 2.01 (1.36 to 2.67)  < 0.001
  1. Data presented are mean (SEM) and mean difference (95%CI), Week 24 minus Baseline